Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Quality of Life After AVR
Quality of Life After AVR

Original Research

Author(s): Meng He , Jinwei Zhang , Jianbo Yu , et al Added: 10 months ago

Heart Failure
Plaque Burden on CCTA Predicts MACE in Early CAD
Added: 1 month ago Source:  Radcliffe Vascular
A post hoc analysis of the PROMISE trial has found that quantitative coronary plaque measures derived from coronary computed tomographic angiography (CCTA) can independently predict major adverse cardiovascular events (MACE) in symptomatic patients without a known history of coronary artery disease (CAD).¹ The findings suggest that total plaque burden and noncalcified plaque burden may enhance… View more

Imaging & Diagnostics

Prevention & Chronic Conditions
Author(s): Jacob E Møller , Christian Schulze , Andreas Goetzenich , et al Added: 4 months ago
Gain critical insights into how the landmark DanGer Shock RCT reshaped cardiogenic shock management, improved patient outcomes and enhanced collaborative care strategies in real-world settings.In this webinar, leading experts and trial investigators Dr Jacob Møller (Copenhagen University Hospital, Copenhagen, DK), Dr Vasileios Panoulas (Harefield Hospital, London, UK), Prof Christian Schulze … View more

Intervention

MI/ACS
Post-PE Syndrome and Transcatheter Therapy
Author(s): Belén Biscotti Rodil , Juan Duarte Torres , Irene Martín de Miguel , et al Added: 3 months ago

Intervention

Heart Failure
Aldosterone Synthase Inhibitors
Author(s): Shubh K Patel , Hwee Teoh , Ahreni Saunthar , et al Added: 8 months ago

Cardiovascular Renal Metabolic

Heart Failure
Malnutrition and Prognosis in Elderly Patients with Chronic Heart Failure
Author(s): Mohammed El-Sheikh , Nora Olsen El Caidi , Aginsha Kandiah , et al Added: 5 months ago

Cardiovascular Renal Metabolic

Heart Failure
HFSA 24: The EMBARK HFpEF Trial
Author(s): Added: 1 year ago
HFSA 24 - We are joined virtually by Dr Sanjiv Shah to discuss the primary results from EMBARK HFpEF (NCT04766892).EMBARK HFpEF is a phase 2a proof-of-concept study assessing the safety, tolerability and preliminary efficacy of mavacamten treatment on myosin biomarkers in patients with heart failure with preserved ejection fractions (HFpEF) and elevated NT-proBNP.Interview Questions:What is the… View more

Heart Failure
Author(s): Julian Gillmore , Margot K Davis , Ahmad Masri , et al Added: 1 year ago
First presented at ESC 2024, this on-demand programme sees Prof Julian Gillmore (University College London, London, UK) lead a distinguished faculty compromising of Dr Ahmad Masri (Oregon Health & Science University Medical Group, Portland, US), Dr Margot Davis (University of British Columbia, Vancouver, CA), and Dr Giuseppe Vergaro (Sant’Anna, Pisa, IT).The faculty present recent epidemiological… View more

Heart Failure
ESC Congress 2024 Reveals its Late-Breaking Scientific Sessions
Added: 1 year ago Source:  ESC Congress
The European Society of Cardiology has revealed the late-breaking science sessions to be presented at the end of August.ESC Congress 2024 will be held from the 30th August to the 2nd September at the ExCel Center in London. View the full programme here.Don't miss our video collection covering late-breaking data from ESC Congress 2024, including a preview of the most anticipated trials in View… View more

Heart Failure

Electrophysiology & Arrhythmia
Heart Failure 2024
Author(s): Harriette Van Spall , Mark Petrie Added: 1 year ago
Discover the latest heart failure data from impactful trials and studies presented at the Heart Failure Association’s annual congress, Heart Failure 2024.Dive deep into novel data with in-depth and critical discussions led by Late-breaker host Dr Harriette Van Spall and her expert guests.For quick and practical summaries of the late-breaking trials, watch our 5-minute Expert Interviews conducted… View more

Heart Failure